(Q40465162)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

title

Low Intratumoral Mast Cells Are Associated With a Higher Risk of Prostate Cancer Recurrence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Toby Cornish

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

7

Angelo M De Marzo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

6

Elizabeth A Platz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

author name string

Heidi A Hempel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Nathan S Cuka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

John R Barber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Karen S Sfanos

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

language of work or name

1 reference

21 November 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

page(s)

412-424

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

Molecular link mechanisms between inflammation and cancer

27 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Inflammatory alterations of the extracellular matrix in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Mast cells: the Jekyll and Hyde of tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Prostate cancer and inflammation: the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Epidemiology of inflammation and prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

CCL2 is a potent regulator of prostate cancer cell migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Alteration of protease expression phenotype of mouse peritoneal mast cells by changing the microenvironment as demonstrated by in situ hybridization histochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Mast cells and cancer--no longer just basic science

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

The dark side of mast cell-targeted therapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

The significant role of mast cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

The human mast cell: functions in physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Mast cells as a potential prognostic marker in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Mast cells as regulators of adaptive immunity to tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple Sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Mast cell variations in tumour tissue and with histopathological grading in specimens of prostatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Mast cell tryptase: a review of its physiology and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Immunohistological analysis of mast cell numbers in the intratumoral and peritumoral regions of prostate carcinoma compared to benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

NIH Image to ImageJ: 25 years of image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23280

21 January 2018

Identifiers

DOI

10.1002/PROS.23280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27868214%20AND%20SRC:MED&resulttype=core&format=json

release_jtbhkbdxzzginh63fpjn5aiv7y

27 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jtbhkbdxzzginh63fpjn5aiv7y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference